ENO1 and cancer: An unpaired t-test revealed a significant difference between benign and malignant tumors (p=0.0035 and CI=-56.44 to -9.409), indicating that the intensity of ENO1 immunohistochemical staining is directly related to the type of breast tumor (Figure 1C).